Recent vaccination announcements have led to some confusion. Four physicians weigh in on who should get vaccinated and when ...

Robert Malone, who believes the U.S. government has “reality-bending information-control capabilities,” will guide the future ...

The rewriting of government recommendations will make the effort to get vaccine doses into arms exponentially more difficult, ...

BioNTech won a major shot in the arm for its cancer drug activities last week when Bristol Myers Squibb agreed to pay up to ...

(HealthDay News) — The U.S. Food and Drug Administration has approved a new lower-dose vaccine for active immunization against COVID-19 caused by severe acute respiratory syndrome coronavirus 2.

MRNA wins FDA approval for mNexspike, a fridge-stable COVID shot, but with a narrower use label than it sought.

CureVac shares skyrocketed 35% Thursday when the biotech firm agreed to be bought by COVID-19 vaccine maker BioNTech in an all-stock deal valued at about $1.25 billion.

The vaccines marked a breakthrough in medical technology, drastically reducing the timeline for development of targeted ...

Luton, Bedfordshire, United Kingdom, June 16, 2025 (GLOBE NEWSWIRE) -- The global mRNA vaccine core enzyme market is witnessing unprecedented growth, driven by heightened demand for rapid vaccine ...

The new members include well-known vaccine skeptics and others who have been critical of Covid vaccines or pandemic ...

Moderna convinced a U.S. appeals court on Wednesday to uphold a ruling that undercut patent infringement claims by biotech ...